Clinical trial Recruiting at 1 site Interventional

Training physicians in anal cancer screening and treatment in Nigeria

Official title: Integrated Model for the Prevention of Anal Cancer Using Screen and Treat for High-grade Intraepithelial Lesions (IMPACT)

Run by University of Maryland, Baltimore · NCT05817370 · Data updated 2026-11-12

This study is testing two different training programs for doctors in Nigeria to see which one helps them better screen for and treat anal cancer within the context of HIV care.

More Medical Education trials

Quick facts

Study typeInterventional
SexAll
Enrollment1 (estimated)
SponsorUniversity of Maryland, Baltimore
Academic / other
Locations1 site (Abuja)
StatusRecruiting
StartedMay 2, 2023
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedJuly 30, 2026
Trial IDNCT05817370 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are physicians with a medical degree and experience in HIV/AIDS care in Nigeria.

Probably not a fit

Patients who are not healthcare providers or those without experience in HIV/AIDS care may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests two training protocols for physicians on anal cancer screening and treatment, comparing a standard protocol from high-income settings with a tailored protocol for Nigeria. The research aims to identify barriers to learning the procedure and develop strategies to enhance training effectiveness. An implementation science committee will co-design an improved training program, which will then be evaluated through a Hybrid Type 2 trial to monitor outcomes over time. The study focuses on integrating anal cancer care into existing HIV treatment frameworks.

Why it matters

Potential benefit: If successful, this study could improve the capacity of healthcare providers in Nigeria to effectively screen and treat anal cancer, potentially reducing cancer incidence in high-risk populations.

How similar studies have gone: While similar training interventions have been implemented in other contexts, this specific approach tailored to the Nigerian setting is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Possess a medical degree in medical sciences (MBBS or equivalent)
2. At least 2-5 years of experience working with clinical HIV/AIDS community
3. Must be registered with the medical and dental council of Nigeria
4. Possess a current medical practicing license
5. Willing to work with the Sexual Gender Minority Community

Exclusion Criteria:

Where it's running

  • International Center for Advocacy on Right to Health (ICARH)
    Abuja, Nigeria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.